Tianan Pharmaceutical Valuation
| TNPH Stock | USD 0.01 0.00 0.00% |
Tianan Pharmaceutical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Tianan Pharmaceutical from inspecting the company fundamentals such as Return On Equity of 0.25, operating margin of 0.36 %, and Price To Earning of 0.15 X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Tianan Pharmaceutical's price fluctuation is out of control at this time. Calculation of the real value of Tianan Pharmaceutical is based on 3 months time horizon. Increasing Tianan Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tianan Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tianan Pink Sheet. However, Tianan Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0052 | Real 0.004774 | Hype 0.007033 | Naive 0.005173 |
The intrinsic value of Tianan Pharmaceutical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Tianan Pharmaceutical's stock price.
Estimating the potential upside or downside of Tianan Pharmaceutical Co helps investors to forecast how Tianan pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tianan Pharmaceutical more accurately as focusing exclusively on Tianan Pharmaceutical's fundamentals will not take into account other important factors: Tianan Pharmaceutical Total Value Analysis
Tianan Pharmaceutical Co is at this time projected to have valuation of 979.64 K with market capitalization of 17.29 M, debt of 0, and cash on hands of 8.23 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tianan Pharmaceutical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
979.64 K | 17.29 M | 0 | 8.23 M |
Tianan Pharmaceutical Investor Information
The company has price-to-book ratio of 1.2. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tianan Pharmaceutical had not issued any dividends in recent years. Based on the analysis of Tianan Pharmaceutical's profitability, liquidity, and operating efficiency, Tianan Pharmaceutical Co is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Tianan Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tianan Pharmaceutical has an asset utilization ratio of 69.23 percent. This signifies that the Company is making $0.69 for each dollar of assets. An increasing asset utilization means that Tianan Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.Tianan Pharmaceutical Profitability Analysis
The company reported the previous year's revenue of 10.65 M. Net Income was 3.14 M with profit before overhead, payroll, taxes, and interest of 7.3 M.About Tianan Pharmaceutical Valuation
An absolute valuation paradigm, as applied to Tianan Pink Sheet, attempts to find the value of Tianan Pharmaceutical based on its fundamental and basic technical indicators. By analyzing Tianan Pharmaceutical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Tianan Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tianan Pharmaceutical. We calculate exposure to Tianan Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tianan Pharmaceutical's related companies.Tianan Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. The company was founded in 2003 and is based in Xian, China. TianAn Pharm is traded on OTC Exchange in the United States.
8 Steps to conduct Tianan Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Tianan Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tianan Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tianan Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tianan Pharmaceutical's revenue streams: Identify Tianan Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tianan Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tianan Pharmaceutical's growth potential: Evaluate Tianan Pharmaceutical's management, business model, and growth potential.
- Determine Tianan Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tianan Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Tianan Pharmaceutical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Quarterly Earnings Growth Y O Y | 0.712 | |
| Retained Earnings | 5.8 M |
Complementary Tools for Tianan Pink Sheet analysis
When running Tianan Pharmaceutical's price analysis, check to measure Tianan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tianan Pharmaceutical is operating at the current time. Most of Tianan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Tianan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tianan Pharmaceutical's price. Additionally, you may evaluate how the addition of Tianan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance |